162 related articles for article (PubMed ID: 32079093)
1. Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity.
Elmowafy M; Alruwaili NK; Shalaby K; Alharbi KS; Altowayan WM; Ahmad N; Zafar A; Elkomy M
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32079093
[TBL] [Abstract][Full Text] [Related]
2. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells.
Sigfridsson K; Skantze U; Skantze P; Johansson S; Grant I; Smedsrød B; Fuglesteg B; Elvevold K; Lindfors L
Int J Pharm; 2017 Feb; 518(1-2):29-40. PubMed ID: 28012994
[TBL] [Abstract][Full Text] [Related]
4. Varying the sustained release of BMP-2 from chitosan nanogel-functionalized polycaprolactone fiber mats by different polycaprolactone surface modifications.
Sundermann J; Oehmichen S; Sydow S; Burmeister L; Quaas B; Hänsch R; Rinas U; Hoffmann A; Menzel H; Bunjes H
J Biomed Mater Res A; 2021 May; 109(5):600-614. PubMed ID: 32608183
[TBL] [Abstract][Full Text] [Related]
5. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles.
Ebrahimi HA; Javadzadeh Y; Hamidi M; Jalali MB
Daru; 2015 Sep; 23(1):46. PubMed ID: 26392174
[TBL] [Abstract][Full Text] [Related]
6. The Inclusion of Chitosan in Poly-ε-caprolactone Nanoparticles: Impact on the Delivery System Characteristics and on the Adsorbed Ovalbumin Secondary Structure.
Jesus S; Fragal EH; Rubira AF; Muniz EC; Valente AJM; Borges O
AAPS PharmSciTech; 2018 Jan; 19(1):101-113. PubMed ID: 28612189
[TBL] [Abstract][Full Text] [Related]
7. Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients.
Zaki NM
Drug Deliv; 2014 Jun; 21(4):265-75. PubMed ID: 24093513
[TBL] [Abstract][Full Text] [Related]
8. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures.
Mistry PH; Mohapatra SK; Dash AK
Nanomedicine (Lond); 2012 Dec; 7(12):1863-76. PubMed ID: 22709346
[TBL] [Abstract][Full Text] [Related]
11. In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery.
Deruyver L; Rigaut C; Gomez-Perez A; Lambert P; Haut B; Goole J
Int J Nanomedicine; 2023; 18():1085-1106. PubMed ID: 36883068
[TBL] [Abstract][Full Text] [Related]
12. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine.
Tuğcu-Demiröz F; Saar S; Kara AA; Yıldız A; Tunçel E; Acartürk F
Eur J Pharm Sci; 2021 Jun; 161():105801. PubMed ID: 33691155
[TBL] [Abstract][Full Text] [Related]
14. Influence of Stabilizer on the Development of Luteolin Nanosuspension for Cutaneous Delivery: An In Vitro and In Vivo Evaluation.
Elmowafy M; Shalaby K; Al-Sanea MM; Hendawy OM; Salama A; Ibrahim MF; Ghoneim MM
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834227
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Folate Ligand Density on the Targeting Property of Folated-Conjugated Polymeric Nanoparticles.
Gong YC; Xiong XY; Ge XJ; Li ZL; Li YP
Macromol Biosci; 2019 Feb; 19(2):e1800348. PubMed ID: 30444303
[TBL] [Abstract][Full Text] [Related]
17. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
Alkholief M; Kalam MA; Anwer MK; Alshamsan A
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Graphene-Based Nanosheets with Pluronic F127-Chitosan Biopolymers Encapsulated α-Mangosteen Drugs for Breast Cancer Cells Therapy.
Hardiansyah A; Randy A; Dewi RT; Angelina M; Yudasari N; Rahayu S; Ulfah IM; Maryani F; Cheng YW; Liu TY
Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956678
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-decorated and tripolyphosphate-crosslinked pH-sensitive niosomal nanogels for Controlled release of fluoropyrimidine 5-fluorouracil.
Ahmed MM; Ameen MSM; Abazari M; Badeleh SM; Rostamizadeh K; Mohammed SS
Biomed Pharmacother; 2023 Aug; 164():114943. PubMed ID: 37267634
[TBL] [Abstract][Full Text] [Related]
20. Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy.
Cover NF; Lai-Yuen S; Parsons AK; Kumar A
Int J Nanomedicine; 2012; 7():2411-9. PubMed ID: 22811601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
